| Revision as of 16:40, 8 January 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to watched fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Misplaced Pages← Previous edit | Revision as of 09:23, 23 February 2011 edit undoAnypodetos (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers39,350 editsm Sufficient refs for the contents of this stubNext edit → | ||
| Line 1: | Line 1: | ||
| {{Refimprove|date=December 2009}} | |||
| {{Drugbox | {{Drugbox | ||
| | Watchedfields = changed | | Watchedfields = changed | ||
| Line 34: | Line 33: | ||
| | routes_of_administration = Oral | | routes_of_administration = Oral | ||
| }} | }} | ||
| '''Amlodipine/benazepril''', marketed in the U.S. as '''Lotrel''' by ] and manufactured as a ] by ] and ], is an ] medication which combines a ] (] besilate) with an ] (]).<ref></ref> This drug, like similar combinations, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the ] profile of both of its individual parts. | '''Amlodipine/benazepril''', marketed in the U.S. as '''Lotrel''' by ] and manufactured as a ] by ] and ], is an ] medication which combines a ] (] besilate) with an ] (]).<ref></ref> This drug, like similar combinations, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the ] profile of both of its individual parts.<ref>Drugs.com: </ref><ref>RxList.com: </ref> | ||
| == See also == | == See also == | ||
| Line 45: | Line 44: | ||
| ==External links== | ==External links== | ||
| * ]: | * ]: | ||
| * Drugs.com: | |||
| * RxList.com: | |||
| {{Calcium channel blockers}} | {{Calcium channel blockers}} | ||
Revision as of 09:23, 23 February 2011
Pharmaceutical compound | |
 | |
| Combination of | |
|---|---|
| Amlodipine | Calcium channel blocker |
| Benazepril | ACE inhibitor |
| Clinical data | |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva and Sandoz, is an antihypertensive medication which combines a calcium channel blocker (amlodipine besilate) with an angiotensin converting enzyme inhibitor (benazepril). This drug, like similar combinations, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.
See also
References
- Lotrel Prescribing Information
- Drugs.com: Lotrel
- RxList.com: Lotrel
External links
| Antihypertensive drugs acting on the renin–angiotensin system (C09) | |
|---|---|
| ACE inhibitors ("-pril") |
|
| AIIRAs ("-sartan") |
|
| Renin inhibitors ("-kiren") | |
| Dual ACE/NEP inhibitors | |
| Neprilysin inhibitors | |
| Other | |
| |
 | This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |